Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 5 | 2019 | 286 | 2.590 |
Why?
|
| Premature Birth | 7 | 2022 | 148 | 1.450 |
Why?
|
| Thyroid Diseases | 2 | 2019 | 33 | 1.370 |
Why?
|
| Pregnancy | 18 | 2022 | 2331 | 1.160 |
Why?
|
| Hyperparathyroidism | 2 | 2019 | 40 | 1.130 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 30 | 0.720 |
Why?
|
| Hypoparathyroidism | 1 | 2019 | 4 | 0.710 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2019 | 16 | 0.700 |
Why?
|
| Thyroid Nodule | 1 | 2019 | 15 | 0.690 |
Why?
|
| Hypothyroidism | 1 | 2019 | 24 | 0.690 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2019 | 91 | 0.660 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 68 | 0.650 |
Why?
|
| Chorioamnionitis | 2 | 2015 | 40 | 0.640 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2019 | 20 | 0.630 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 1026 | 0.610 |
Why?
|
| Endometritis | 2 | 2015 | 29 | 0.600 |
Why?
|
| Conservative Treatment | 1 | 2015 | 8 | 0.550 |
Why?
|
| Patient Preference | 1 | 2015 | 57 | 0.520 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2015 | 50 | 0.520 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2015 | 45 | 0.520 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 60 | 0.510 |
Why?
|
| Sepsis | 2 | 2015 | 233 | 0.480 |
Why?
|
| Thyroid Crisis | 1 | 2013 | 6 | 0.450 |
Why?
|
| Hypercalcemia | 1 | 2013 | 34 | 0.450 |
Why?
|
| Fluid Therapy | 1 | 2013 | 59 | 0.440 |
Why?
|
| Female | 21 | 2022 | 38015 | 0.420 |
Why?
|
| Obstetric Labor, Premature | 2 | 2015 | 76 | 0.360 |
Why?
|
| Infant, Newborn | 7 | 2022 | 2453 | 0.360 |
Why?
|
| Insulin | 1 | 2013 | 617 | 0.360 |
Why?
|
| Thyroid Function Tests | 2 | 2019 | 21 | 0.350 |
Why?
|
| Humans | 22 | 2022 | 68525 | 0.310 |
Why?
|
| Cefazolin | 1 | 2007 | 19 | 0.310 |
Why?
|
| Cesarean Section | 1 | 2007 | 101 | 0.290 |
Why?
|
| Maternal Mortality | 1 | 2005 | 16 | 0.270 |
Why?
|
| Bacterial Infections | 1 | 2007 | 163 | 0.270 |
Why?
|
| Obstetrics | 1 | 2005 | 44 | 0.260 |
Why?
|
| Pregnancy, Multiple | 1 | 2004 | 32 | 0.240 |
Why?
|
| Prenatal Care | 2 | 2018 | 117 | 0.230 |
Why?
|
| Eyelid Diseases | 1 | 2003 | 7 | 0.230 |
Why?
|
| Contracture | 1 | 2003 | 15 | 0.230 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 51 | 0.220 |
Why?
|
| Physicians | 1 | 2005 | 324 | 0.200 |
Why?
|
| Sewage | 1 | 2019 | 23 | 0.180 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 2 | 0.180 |
Why?
|
| Propylthiouracil | 1 | 2019 | 8 | 0.180 |
Why?
|
| Methimazole | 1 | 2019 | 9 | 0.180 |
Why?
|
| Antithyroid Agents | 1 | 2019 | 20 | 0.180 |
Why?
|
| Collagen | 1 | 2003 | 636 | 0.180 |
Why?
|
| Preconception Care | 1 | 2019 | 14 | 0.180 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2019 | 3 | 0.180 |
Why?
|
| Hypocalcemia | 1 | 2019 | 13 | 0.180 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 17 | 0.180 |
Why?
|
| Microphthalmos | 1 | 2019 | 9 | 0.180 |
Why?
|
| Calcium, Dietary | 1 | 2019 | 35 | 0.170 |
Why?
|
| Thyroidectomy | 1 | 2019 | 31 | 0.170 |
Why?
|
| Hyperopia | 1 | 2019 | 14 | 0.170 |
Why?
|
| Retrospective Studies | 5 | 2019 | 7264 | 0.170 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 76 | 0.170 |
Why?
|
| Postoperative Complications | 2 | 2007 | 1615 | 0.170 |
Why?
|
| Thyroxine | 1 | 2019 | 62 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2019 | 67 | 0.170 |
Why?
|
| Fetal Development | 1 | 2019 | 70 | 0.170 |
Why?
|
| Magnesium Sulfate | 1 | 2018 | 6 | 0.170 |
Why?
|
| Calcitriol | 1 | 2019 | 106 | 0.170 |
Why?
|
| Vitamins | 1 | 2019 | 134 | 0.160 |
Why?
|
| Antibodies | 1 | 2019 | 241 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 117 | 0.160 |
Why?
|
| Retinal Degeneration | 1 | 2019 | 75 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 50 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 85 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2019 | 311 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 331 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 292 | 0.140 |
Why?
|
| Adult | 8 | 2019 | 21375 | 0.140 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2016 | 17 | 0.140 |
Why?
|
| Prospective Studies | 5 | 2020 | 3702 | 0.140 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 317 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.130 |
Why?
|
| Body Fluids | 1 | 2015 | 41 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 848 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2015 | 64 | 0.130 |
Why?
|
| Rural Population | 1 | 2018 | 397 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2019 | 753 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.130 |
Why?
|
| Vitamin D | 1 | 2019 | 516 | 0.130 |
Why?
|
| Vagina | 1 | 2015 | 87 | 0.130 |
Why?
|
| Sexual Behavior | 1 | 2015 | 179 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2015 | 200 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 445 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 581 | 0.120 |
Why?
|
| Fetal Monitoring | 1 | 2013 | 20 | 0.110 |
Why?
|
| North America | 1 | 2013 | 111 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2013 | 122 | 0.110 |
Why?
|
| Pregnancy in Diabetics | 1 | 2013 | 70 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2013 | 88 | 0.110 |
Why?
|
| Age Factors | 1 | 2015 | 1860 | 0.100 |
Why?
|
| HIV Infections | 1 | 2018 | 775 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1851 | 0.090 |
Why?
|
| Gestational Age | 2 | 2022 | 389 | 0.090 |
Why?
|
| Proteomics | 2 | 2022 | 246 | 0.080 |
Why?
|
| Biomarkers | 3 | 2022 | 1593 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 772 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.080 |
Why?
|
| Umbilical Cord | 1 | 2007 | 19 | 0.080 |
Why?
|
| Constriction | 1 | 2007 | 37 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 62 | 0.070 |
Why?
|
| Medicaid | 1 | 2008 | 301 | 0.070 |
Why?
|
| Pregnancy, High-Risk | 1 | 2005 | 14 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 168 | 0.070 |
Why?
|
| Middle Aged | 3 | 2019 | 21119 | 0.070 |
Why?
|
| Aged | 2 | 2015 | 14842 | 0.060 |
Why?
|
| Health Promotion | 1 | 2008 | 407 | 0.060 |
Why?
|
| ROC Curve | 2 | 2016 | 392 | 0.060 |
Why?
|
| Orbital Neoplasms | 1 | 2003 | 21 | 0.060 |
Why?
|
| Leiomyoma | 1 | 2003 | 28 | 0.060 |
Why?
|
| Palate, Hard | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2020 | 2356 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2007 | 1737 | 0.060 |
Why?
|
| United States | 3 | 2020 | 7335 | 0.060 |
Why?
|
| Logistic Models | 2 | 2018 | 1419 | 0.060 |
Why?
|
| Risk Factors | 2 | 2018 | 5719 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 1753 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2003 | 247 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1465 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 503 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 8 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 13 | 0.040 |
Why?
|
| Exons | 1 | 2019 | 122 | 0.040 |
Why?
|
| Refractive Errors | 1 | 2019 | 24 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 159 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7028 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 4655 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2019 | 220 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 2004 | 0.040 |
Why?
|
| South Carolina | 2 | 2018 | 2750 | 0.040 |
Why?
|
| Family | 1 | 2019 | 293 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 58 | 0.030 |
Why?
|
| Male | 4 | 2019 | 37281 | 0.030 |
Why?
|
| Amniocentesis | 1 | 2015 | 12 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 284 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 507 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 330 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 4843 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2790 | 0.030 |
Why?
|
| Child | 2 | 2019 | 6400 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 3185 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 2891 | 0.030 |
Why?
|
| Case Management | 1 | 2008 | 46 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 157 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 8472 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2008 | 383 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 349 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 20877 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 508 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 2323 | 0.010 |
Why?
|